FT Health Discusses Global Impacts Of Dementia, Features Interview With Takeda CEO Christophe Weber

FT Health: The need for fresh approaches on dementia
The latest issue of the Financial Times’ weekly global health newsletter highlights the global costs of dementia, the WHO’s new Global Dementia Observatory, and the Financial Times’ seasonal appeal for Alzheimer’s research. The newsletter also features an interview with Christophe Weber, chief executive of Japanese pharmaceutical company Takeda, and a roundup of other global health-related news stories (Jack/Dodd, 12/8).